Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/10641963.2021.1937205 http://scihub22266oqcxt.onion/10.1080/10641963.2021.1937205 34225505!ä!34225505 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Exp+Hypertens 2021 ; 43 (7): 683-689 Nephropedia Template TP {{tp|p=34225505|t=2021. Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients |pdf=|usr=}}{{34225505}} gab.com Text Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients JO: Clin Exp Hypertens http://www.kidney.de/pget.php?&tw=1&pmid=34225505 #FOAvip OBJECTIVES: The aim of this study was to investigate the relationship between the C-reactive protein/albumin ratio and the prognosis of hypertensive COVID-19 patients. METHODS: It was designed as a single center retrospective study. PCR positive COVID-19 patients who were followed up in the intensive care unit (ICU) and received antihypertensive treatment were included in the study. The patients were divided into two groups as survivor and non-survivor. C-reactive protein/albumin (CAR) ratios of the patients were compared. The cut-off value was determined as a mortality predictor. The effect of CAR on mortality was evaluated using Logistic Regression analysis. RESULTS: 281 patients were included in the study. Groups consisted of 135 (non-survivor) and 146 (survivor) patients. CAR was significantly higher in the non-survivor group (p<0.001). The area under the ROC curve for CAR for mortality was 0.807, with sensitivity of 0.71 and specificity of 0.71. The cut-off value for CAR was calculated as 56.62. In logistic regression analysis, CAR increases mortality 4.9 times compared to the cut-off value. CONCLUSION: CAR is a powerful and independent prognostic marker for predicting mortality and disease progression in hypertensive COVID-19 patients. Twit Text FOAVip Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients ????Clin Exp Hypertens http://www.kidney.de/pget.php?&tw=1&pmid=34225505 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34225505 #FOAvip English Wikipedia <ref>{{Cite pmid|34225505}}</ref> Prognostic value of C-reactive protein/albumin ratio in hypertensive COVID-19 patients #MMPMID34225505 Ozdemir IH; Ozlek B; Ozen MB; Gunduz R; Cetin N; Ozlek E; Yildiz BS; Bilge AR Clin Exp Hypertens 2021[Oct]; 43 (7): 683-689 PMID34225505show ga OBJECTIVES: The aim of this study was to investigate the relationship between the C-reactive protein/albumin ratio and the prognosis of hypertensive COVID-19 patients. METHODS: It was designed as a single center retrospective study. PCR positive COVID-19 patients who were followed up in the intensive care unit (ICU) and received antihypertensive treatment were included in the study. The patients were divided into two groups as survivor and non-survivor. C-reactive protein/albumin (CAR) ratios of the patients were compared. The cut-off value was determined as a mortality predictor. The effect of CAR on mortality was evaluated using Logistic Regression analysis. RESULTS: 281 patients were included in the study. Groups consisted of 135 (non-survivor) and 146 (survivor) patients. CAR was significantly higher in the non-survivor group (p<0.001). The area under the ROC curve for CAR for mortality was 0.807, with sensitivity of 0.71 and specificity of 0.71. The cut-off value for CAR was calculated as 56.62. In logistic regression analysis, CAR increases mortality 4.9 times compared to the cut-off value. CONCLUSION: CAR is a powerful and independent prognostic marker for predicting mortality and disease progression in hypertensive COVID-19 patients. |*COVID-19/complications/diagnosis[MESH] |*Hypertension/diagnosis/virology[MESH] |C-Reactive Protein/analysis[MESH] |Humans[MESH] |Prognosis[MESH] |Retrospective Studies[MESH]Prognostic value of C-reactive protein/albumin ratio in hypertensive C(epmc).pdf DeepDyve Pubget Overpricing